Nexien BioPharma (NXEN) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 1 18 sessions, November 3, 2025 to November 2, 2026
- Largest daily move
- -94.4% close of November 10, 2025
Company Description
Nexien BioPharma (OTC: NXEN) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $7.1K.
NXEN has gained 0.0% over the past week. The last closing price was $0.0001.
For FY2024, Nexien BioPharma reported diluted earnings per share of $0.00.
This page collects what Stock Titan holds for NXEN, including price data, latest news, SEC filings, and financial highlights.
Stock Performance
Nexien BioPharma (NXEN) closed at $0.0001 on November 2, 2026. Over the past week, the price has gained 0.0%.
NXEN Metrics & Rankings
Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Nexien BioPharma has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all NXEN news →
SEC Filings
Nexien BioPharma has filed 1 recent SEC filing, including 1 Form 15-12G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NXEN SEC filings →
Financial Highlights
Upcoming Events
NXEN Company Profile & Sector Positioning
Nexien BioPharma (NXEN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NXEN often look at related companies in the same sector, including CEN Biotech Inc (CENBF), 4Front Ventures Corp (FFNTF), Bespoke Extracts Inc (BSPK), Radient Tech Inc (RDDTF), and Advantis Corp (ADVT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NXEN's relative position within its industry.